Some studies demonstrate increased E2F2 gene expression in cancers such as ovarian cancer, non-small cell lung cancer, hepatocellular carcinoma and breast cancer [35,36,37,38]. This evidence concerns the gene E2F2 and hepatocellular carcinoma.